Market Tracker

04/23 8:26am ET

Exelixis Inc (NASDAQ:EXEL)

3.58
Data as of Apr 22
 +0.23 / +6.87%
Today’s Change
3.02
Today|||52-Week Range
8.41
-41.60%
Year-to-Date

Today’s Trading

Previous close3.35
Today’s open3.37
Day’s range-- - --
Volume4,192,473
Average volume (3 months)5,503,625
Market cap$640.3M
Dividend yield--
Data as of 04/22/2014

Growth & Valuation

Earnings growth (last year)-44.57%
Earnings growth (this year)-13.05%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-33.96%
P/E ratioNM
Price/Sales36.00
Price/Book9.17

Competitors

 Today’s
change
Today’s
% change
ARWRArrowhead Research C...+0.38+2.89%
NXTMNxStage Medical Inc-0.18-1.48%
BRLIBio-Reference Labora...-0.12-0.44%
AMRIAlbany Molecular Res...+0.28+1.69%
Data as of 04/22/2014

Financials

Next reporting dateMay 2, 2014
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$31.3M
Annual profit (last year)-$244.8M
Net profit margin-781.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Frank L. Karbe
Corporate headquarters
South San Francisco, California

Forecasts